The removal of strontium from the mouse by chelating agents.
The effects of the chelating agents monosodium glutamate, Tiron, tartaric acid, ascorbic acid, 1,4,7,10,13,16-hexaoxacyclooctadecane (18-crown-6), 2,3-dimercaptosuccinic acid (DMSA), succinic acid, malic acid, ethylendiaminetetraacetic acid (EDTA), ethylenglycol-bis-(beta-amino-ethylether)-N,N'tetraacetic acid (EGTA), cyclohexane-diaminetetraacetic acid (CDTA) and diethylentria-minepentaacetic acid (DTPA) on the distribution and excretion of intraperitoneally injected strontium were investigated in male Swiss mice. Strontium nitrate was given at a dose equal to 3.78 mmol/kg and ten minutes after, chelators were administered intraperitoneally at doses approximately equal to one-fourth of their respective LD50 values. DTPA, followed by CDTA, EDTA and tartaric acid, was consistently the most effective in increasing the urinary excretion of strontium. Only ascorbic acid increased significantly the fecal excretion of strontium. CDTA, DTPA and ascorbic acid were also the most effective chelators in reducing the concentration of strontium found in various tissues. CDTA, DTPA and tartaric acid are the most effective agents of those tested in the removal of strontium after a single administration.
Ortega
A
A
Gómez
M
M
Domingo
J L
JL
Corbella
J
J
D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology*; D004492:Edetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D005243:Feces / Q000032:analysis; D008297:Male; D051379:Mice; D004369:Pentetic Acid / Q000494:pharmacology; D011832:Radiation Injuries / Q000517:prevention & control; D013324:Strontium / Q000493:pharmacokinetics* / Q000652:urine; D013326:Strontium Radioisotopes; D013644:Tartrates / Q000494:pharmacology; D014018:Tissue Distribution
D002614:Chelating Agents; D013326:Strontium Radioisotopes; D013644:Tartrates; C005390:CDTA; D004369:Pentetic Acid; D004492:Edetic Acid; D013324:Strontium